Morgan Stanley’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $54M | Sell |
209,082
-12,399
| -6% | -$3.3M | ﹤0.01% | 2023 |
|
|
2025
Q4 | $54.6M | Sell |
221,481
-13,097
| -6% | -$2.76M | ﹤0.01% | 1993 |
|
|
2025
Q3 | $41.4M | Buy |
234,578
+157
| +0.1% | +$23.5K | ﹤0.01% | 2179 |
|
|
2025
Q2 | $32.2M | Sell |
234,421
-63,784
| -21% | -$9.37M | ﹤0.01% | 2339 |
|
|
2025
Q1 | $53.8M | Buy |
298,205
+41,930
| +16% | +$7.05M | ﹤0.01% | 1750 |
|
|
2024
Q4 | $40.1M | Sell |
256,275
-19,529
| -7% | -$3.46M | ﹤0.01% | 2043 |
|
|
2024
Q3 | $50.2M | Sell |
275,804
-42,523
| -13% | -$8.2M | ﹤0.01% | 1818 |
|
|
2024
Q2 | $58.5M | Buy |
318,327
+99,498
| +45% | +$16.7M | ﹤0.01% | 1610 |
|
|
2024
Q1 | $38.9M | Sell |
218,829
-420,613
| -66% | -$58.4M | ﹤0.01% | 1993 |
|
|
2023
Q4 | $79.3M | Buy |
639,442
+350,890
| +122% | +$38.9M | ﹤0.01% | 1968 |
|
|
2023
Q3 | $33.5M | Buy |
288,552
+13,725
| +5% | +$1.67M | ﹤0.01% | 1936 |
|
|
2023
Q2 | $32.3M | Buy |
274,827
+148,002
| +117% | +$15.1M | ﹤0.01% | 1990 |
|
|
2023
Q1 | $10.2M | Buy |
126,825
+60,774
| +92% | +$4.77M | ﹤0.01% | 3124 |
|
|
2022
Q4 | $5.23M | Buy |
66,051
+18,738
| +40% | +$1.39M | ﹤0.01% | 3727 |
|
|
2022
Q3 | $3.3M | Sell |
47,313
-32,041
| -40% | -$2.31M | ﹤0.01% | 4028 |
|
|
2022
Q2 | $5.21M | Buy |
79,354
+7,374
| +10% | +$459K | ﹤0.01% | 3713 |
|
|
2022
Q1 | $4.79M | Sell |
71,980
-39,018
| -35% | -$2.44M | ﹤0.01% | 3739 |
|
|
2021
Q4 | $7.76M | Buy |
110,998
+77,764
| +234% | +$4.53M | ﹤0.01% | 3229 |
|
|
2021
Q3 | $1.74M | Sell |
33,234
-10,217
| -24% | -$605K | ﹤0.01% | 4676 |
|
|
2021
Q2 | $2.95M | Buy |
43,451
+31,745
| +271% | +$2.22M | ﹤0.01% | 4310 |
|
|
2021
Q1 | $901K | Buy |
11,706
+665
| +6% | +$48.3K | ﹤0.01% | 4796 |
|
|
2020
Q4 | $663K | Buy |
11,041
+7,238
| +190% | +$361K | ﹤0.01% | 4904 |
|
|
2020
Q3 | $163K | Sell |
3,803
-1,839
| -33% | -$79.9K | ﹤0.01% | 5209 |
|
|
2020
Q2 | $234K | Buy |
5,642
+3,411
| +153% | +$164K | ﹤0.01% | 5001 |
|
|
2020
Q1 | $96K | Sell |
2,231
-12,960
| -85% | -$678K | ﹤0.01% | 5202 |
|
|
2019
Q4 | $841K | Buy |
15,191
+6,105
| +67% | +$300K | ﹤0.01% | 4635 |
|
|
2019
Q3 | $315K | Sell |
9,086
-15,831
| -64% | -$708K | ﹤0.01% | 4906 |
|
|
2019
Q2 | $1M | Buy |
24,917
+23,002
| +1,201% | +$752K | ﹤0.01% | 4219 |
|
|
2019
Q1 | $63K | Sell |
1,915
-2,085
| -52% | -$49.1K | ﹤0.01% | 5565 |
|
|
2018
Q4 | $83K | Sell |
4,000
-1,366
| -25% | -$28.6K | ﹤0.01% | 5616 |
|
|
2018
Q3 | $94K | Buy |
5,366
+4,170
| +349% | +$70K | ﹤0.01% | 5707 |
|
|
2018
Q2 | $18K | Buy |
+1,196
| New | +$13.4K | ﹤0.01% | 6175 |
|
Other funds holding KRYS
ACA
VPM
VCM
SCM
RG
